US OptionsDetailed Quotes

ACXP240517P2000

Watchlist

0.05
0.000.00%

15min DelayClose May 16 12:02 ET

0.00High0.00Low

Acurx Pharmaceuticals Stock Discussion

Trytosaveabit

May 15 08:01

News

$Acurx Pharmaceuticals(ACXP.US)$ Reuters· just
Acurx Pharmaceuticals Inc: Agreement With FDA Reached on Key Elements to Move Forward With Our International Phase 3 Clinical Trial Program

Jaguar8

May 2 06:02

$Acurx Pharmaceuticals(ACXP.US)$
NEWS
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
Acurx Pharmaceuticals announced the presentation of the Phase 2 clinical trial results of ibezapolstat for C. difficile Infection at ESCMID Global 2024 Scientific Conference. The results showed ibezapolstat's effectiveness in treating CDI and its potential as a therapeutic option against antimicrobial-resistant strains.

Trytosaveabit

Apr 17 15:17

Like! Update

$Acurx Pharmaceuticals(ACXP.US)$ Acurx Pharmaceuticals Withdraws Filing for Stock Offering
Dow Jones· 7 mins ago

Trytosaveabit

Feb 27 06:08

Update

$Acurx Pharmaceuticals(ACXP.US)$ Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

Trytosaveabit

Jan 29 06:02

Update

$Acurx Pharmaceuticals(ACXP.US)$ Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
2 MINUTES AGO, 7:00 AM EST
VIA PR NEWSWIRE

Be a voice no echo

Jan 17 07:14

$Acurx Pharmaceuticals(ACXP.US)$

Trytosaveabit

Jan 17 06:06

Update

$Acurx Pharmaceuticals(ACXP.US)$ Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
4 MINUTES AGO, 7:01 AM EST
VIA PR NEWSWIRE

Sturgeons and Stocks

Dec 11, 2023 07:32

$Acurx Pharmaceuticals(ACXP.US)$

Trytosaveabit

Dec 11, 2023 06:10

Update

$Acurx Pharmaceuticals(ACXP.US)$ Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure

SlowndEasyTrades

Dec 8, 2023 11:07

$Acurx Pharmaceuticals(ACXP.US)$ potential entry 5$ few in oreder test

No comment yet